In this article
If the thought of a weekly injection is what is holding you back, a pill sounds like the easy answer. Semaglutide does come as a tablet. But taking it by mouth changes how much of it gets into your body, how you have to take it, and how predictable it is. Here is what the labels and trials say.
One medicine, two forms
Both forms contain semaglutide, a medicine that acts like the gut hormone GLP-1 to reduce appetite and calorie intake [1]. The FDA-approved semaglutide label for weight management now covers both a once-weekly injection and a once-daily tablet [1].
There is also an older semaglutide tablet used for type 2 diabetes, at lower doses [2]. That one is approved to improve blood sugar control and lower heart risk in adults with type 2 diabetes, not for weight management [2]. The label for the diabetes tablets notes that different semaglutide tablets cannot be swapped milligram for milligram [2].
| Tablet | Injection | |
|---|---|---|
| How often | Once a day | Once a week |
| Starting dose | 1.5 mg daily for 30 days | 0.25 mg weekly for 4 weeks |
| Step-up | 4 mg, then 9 mg, 30 days each | 0.5, 1 and 1.7 mg, 4 weeks each |
| Usual maintenance dose | 25 mg daily | 2.4 mg weekly (1.7 mg is an option) |
| Share of the dose reaching your blood | About 1% to 2% | 89% |
| Food and timing | Empty stomach, then wait 30 minutes | Any time of day, with or without meals |
| Missed dose | Skip it and take the next one the following day | Depends on how soon the next dose is due |
Why the pill is a much bigger dose
Semaglutide is a peptide, a small protein. Your gut is built to break proteins down, so getting it into your blood by mouth is hard. When semaglutide is injected under the skin, about 89% of the dose reaches your bloodstream [1]. When it is swallowed as the approved tablet, only about 1% to 2% does [1]. For the older diabetes tablets, the label puts it at 0.4% to 1% [2].
To get even that much in, the FDA-approved tablets contain an absorption enhancer called SNAC (salcaprozate sodium) [1, 2]. Absorption happens mostly in the stomach [1]. That explains why the tablet dose is so much larger than the injection dose: 25 mg a day by mouth versus 2.4 mg a week by injection [1].
In people without type 2 diabetes, average blood levels on the 25 mg tablet are expected to be comparable to the 2.4 mg injection [1]. But they vary more from person to person. On the tablet, 90% of people had average levels somewhere between 27 and 186 nmol/L, while on the injection the range was 51 to 110 nmol/L [1]. In people with type 2 diabetes, average levels on the tablet were lower than on the injection, and the label says some may not get enough of the drug from the tablet [1].
The empty-stomach rule, and why it matters
Because so little is absorbed, small things can change how much gets in. The label's instructions for the tablet are specific [1]:
- Take one tablet a day, in the morning, on an empty stomach.
- Swallow it with water only, up to 4 ounces (half a cup). No coffee, tea or juice.
- Swallow it whole. Do not split, crush, chew or dissolve it.
- Wait at least 30 minutes before eating, drinking anything else, or taking other pills.
- Do not take more than one tablet a day. If you miss a dose, skip it and take the next one the following day.
The label explains the reasoning with studies in healthy volunteers. Taking a dose with a small amount of water (50 mL, under 2 ounces) led to more absorption than a full glass (240 mL) [1]. And waiting longer after the dose before eating also led to more absorption [1]. Between 50 mL and 120 mL of water, there was no meaningful difference [1].
If your mornings are unpredictable, or you take several other medicines first thing, the tablet's routine can be harder to keep than a once-a-week shot. That is worth being honest with yourself about.
How much weight people lost on each
The 25 mg tablet: OASIS 4
OASIS 4 tested the 25 mg tablet in 307 adults with obesity, or overweight plus a weight-related condition, who did not have diabetes [3]. About four in five were women, and the average age was 48 [1]. Two-thirds took the tablet and one-third took placebo, along with lifestyle advice [3].
After 64 weeks, the tablet group had lost 13.6% of their body weight on average, compared with 2.2% on placebo [3]. They were also more likely to lose 5%, 10%, 15% and 20% or more, and they reported better physical function [3]. Per the label, 47% of the tablet group lost 15% or more of their weight, compared with 5.5% on placebo [1].
A higher 50 mg tablet: OASIS 1
An earlier trial, OASIS 1, tested a higher 50 mg daily tablet in 667 adults without diabetes for 68 weeks. People on the tablet lost 15.1% of their weight on average, compared with 2.4% on placebo [5]. The approved maintenance dose is 25 mg, not 50 mg [1].
The 2.4 mg injection: STEP 1
In STEP 1, 1,961 adults without diabetes took the 2.4 mg weekly injection or placebo for 68 weeks. The injection group lost 14.9% on average, compared with 2.4% on placebo [4].
These were separate trials with different people, lengths and settings, not a head-to-head comparison. The numbers are in the same range, but they cannot tell you which form will work better for you.
Side effects: much the same
The label says the types and frequency of common side effects with the 25 mg tablet were similar to those with the injection [1]. Most are digestive: nausea, diarrhea, vomiting, constipation and stomach pain [1].
- Digestive side effects: reported by 74.0% on the tablet and 42.2% on placebo in OASIS 4 [3]. In the injection trials, 73% on semaglutide and 47% on placebo [1].
- Severe digestive side effects: 2% on the tablet and 0% on placebo [1].
- Stopping because of side effects: about 7% on the tablet and 5.9% on placebo [1].
- Gallstones: 2.5% on the tablet and 1% on placebo [1].
- Altered skin sensation (tingling, burning or sensitive skin): 5% on the tablet and none on placebo [1].
The serious warnings apply to both forms, including the boxed warning about thyroid C-cell tumors seen in rodents, pancreatitis and gallbladder problems [1]. For the full list, see semaglutide side effects.
One tablet-specific point: semaglutide slows the stomach, which can change how other pills are absorbed. In a study with the semaglutide tablet, exposure to levothyroxine, a common thyroid medicine, rose by 33% [1]. If you take thyroid medicine, your clinician may want to check your levels.
Pill or injection: how to decide
Neither form is right for everyone. Questions to talk through with your clinician:
- Would a daily morning routine with a 30-minute wait fit your life, or is once a week easier?
- How do you feel about injections?
- Do you have type 2 diabetes? The label says tablet blood levels can be lower in that group [1].
- What other medicines do you take, especially in the morning or for your thyroid [1]?
The label also allows switching between the two. Someone on the 2.4 mg injection can start the 25 mg tablet one week after their last injection, and someone on the 25 mg tablet can start the 2.4 mg injection the day after their last tablet [1]. Your clinician decides whether and how.
Weighing semaglutide against tirzepatide too? Read semaglutide vs tirzepatide.
Semaglutide at WarriorBabe Health
WarriorBabe Health offers a semaglutide tablet and semaglutide injections, prescribed by licensed clinicians. Ours are compounded by a licensed pharmacy and are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality before they are sold [6].
That matters for the tablet in particular. The absorption figures and trial results above come from the FDA-approved tablets made with SNAC [1, 3]. A compounded tablet is a different product, so those numbers cannot be assumed to apply to it. Follow the instructions on your pharmacy label, and ask your clinician how your tablet should be taken.
Frequently asked questions
Is the semaglutide pill as effective as the injection?
In separate trials, people lost 13.6% of their weight on average on the 25 mg tablet over 64 weeks [3] and 14.9% on the 2.4 mg injection over 68 weeks [4]. There is no head-to-head trial in this article, so the two cannot be ranked directly.
Why do you have to take the semaglutide pill on an empty stomach?
Only about 1% to 2% of a swallowed dose is absorbed, mostly in the stomach [1]. Studies on the label found that less water and a longer wait before eating led to more absorption [1]. So the label says to take it with up to 4 ounces of water and wait at least 30 minutes [1].
Can I drink coffee with the semaglutide pill?
Not at the same time. The label says to take it with water only and to wait at least 30 minutes before drinking any other beverage [1].
Does the pill have fewer side effects than the shot?
Not according to the label, which says the types and frequency of common side effects were similar [1]. In OASIS 4, 74.0% on the tablet and 42.2% on placebo reported digestive side effects [3].
Can I switch from the semaglutide injection to the pill?
The label describes how: someone on the 2.4 mg injection can start the 25 mg tablet one week after the last injection [1]. Whether to switch is a decision for your clinician.
References
- Novo Nordisk. Wegovy (semaglutide) injection and tablets, prescribing information. DailyMed, US National Library of Medicine. Revised 6/2026. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- Novo Nordisk. Rybelsus and Ozempic (semaglutide) tablets, prescribing information. DailyMed, US National Library of Medicine. Revised 1/2026. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98
- Wharton S, Lingvay I, Bogdanski P, et al. Oral semaglutide at a dose of 25 mg in adults with overweight or obesity. N Engl J Med. 2025;393(11):1077-1087. pubmed.ncbi.nlm.nih.gov/40934115/
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. pubmed.ncbi.nlm.nih.gov/33567185/
- Knop FK, Aroda VR, do Vale RD, et al. Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;402(10403):705-719. pubmed.ncbi.nlm.nih.gov/37385278/
- US Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss. www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
This article is for general information. It is not medical advice and does not replace a visit with a licensed clinician who knows your history. Do not start, stop or change a medication without talking to your clinician. If you think you are having a medical emergency, call 911.
